We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 FTSE 100 Stocks To Buy On St. Leger Day: Barclays PLC, GlaxoSmithKline plc & Vodafone Group plc

Here’s why Barclays PLC (LON: BARC), GlaxoSmithKline plc (LON: GSK) and Vodafone Group plc (LON: VOD) could be worth buying right now.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

city

‘Sell in May and don’t come back until St. Leger Day’ is a well-known stock-market saying. In other words, sell shares in May and buy when the St. Leger Day races commence in early September. The reason for the saying is that summer rallies tend to be infrequent and, in fact, history suggests that a summer pullback is not at all uncommon. Indeed, the FTSE 100 is no higher now than it was in May 2014, so those investors who sold up and went away have not missed out on any gains.

XXX

However, it’s now early September and, with the FTSE 100 still failing to push past 7,000 points, this could be a great time to buy the following three stocks.

Barclays

Since the start of May, Barclays (LSE: BARC) has seen its share price fall by 11% as investor sentiment has severely weakened. While this week’s news of a £500 million loss on the sale of part of its Spanish operations may seem like yet more bad news, Barclays continues to make good progress with its disposal programme. Certainly, this will cause short-term pain, but may also set the bank up for improved profitability moving forward.

With shares in the bank trading on a price to earnings (P/E) ratio of just 10.3 and Barclays being forecast to increase its bottom line by an impressive 25% next year, the presently low ebb in sentiment could prove to be an ideal buying opportunity.

GlaxoSmithKline

GlaxoSmithKline (LSE: GSK) is also down 11% since the start of May, with shares in the pharmaceutical major continuing to be hit hard by allegations of bribery. Long-term investors, though, should see this as a buying opportunity as opposed to a reason to panic.

GlaxoSmithKline continues to have a hugely impressive and diversified drugs pipeline which, in the long run, should help the company to considerably grow its bottom line. Furthermore, shares in the company are priced to sell, with GlaxoSmithKline trading on a P/E ratio of just 13 and offering a stunning yield of 5.6%. As with Barclays, weak sentiment could equate to a superb buying opportunity.

Vodafone

It’s a similar story with Vodafone (LSE: VOD): you’d have been better off selling at the start of May, since shares in the company have fallen by 8% since then. However, the future could be much brighter than the past for the European-focused operator, with its strategy of buying undervalued Eurozone assets taking time to come good.

However, should it do so, Vodafone could see its bottom line grow at an impressive rate as it has bought high-quality assets at very attractive prices. In addition, shares in Vodafone currently yield 5.5%, which highlights the company’s income potential at a time when low interest rates look set to be the ‘new normal’.

 

Peter Stephens owns shares of Barclays and GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »